Search Within

Yonina Bykov

Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
  3. Editorial (1)
Groups
  1. Department of Medicine (13)
  2. Gynecology Disease Management Team (13)
  3. Solid Tumor Oncology Division (13)
  4. GDMT, Medicine (12)
  5. Gynecologic Medicine Service (12)
  6. Sloan Kettering Institute Postdocs (10)

More Groups

People
  1. Dmitriy Zamarin (12)
  2. Britta Weigelt (7)
  3. Dennis Chi (5)
  4. Nadeem Abu-Rustum (5)
  5. Sarah Kim (5)
  6. Travis Hollmann (5)

More People

Years
  1. 2024 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (8)
  5. 2019 (1)
Publications
  1. Gynecologic Oncology (3)
  2. Cancer Cell (1)
  3. Cancer Research (1)
  4. Clinical Cancer Research (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. Elsevier Inc. (3)
  2. Nature Publishing Group (3)
  3. American Association for Cancer Research (2)
  4. Academic Press (1)
  5. Amer Assoc Advancement Science (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity
    Journal Article

    Brodeur, M. N.; Dopeso, H.; Zhu, Y.; Longhini, A. L. F.; Gazzo, A.; Sun, S.; Koche, R. P.; Qu, R.; Rosenberg, L.; Hamard, P. J.; more...
    Science Advances (2024)

    Fulltext@MSK | Save
  • Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
    Meeting Abstract

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L.; Wu, M.; Mohibullah, N.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; Fong, C. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Ovarian cancer mutational processes drive site-specific immune evasion
    Journal Article

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L. P.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Systemic and intratumoral stress responses to primary debulking surgery in patients with epithelial ovarian cancer
    Meeting Abstract

    Moukarzel, L. A.; Ferrando, L.; Bykov, Y.; Stylianou, A.; LaVigne, K.; Long Roche, K.; Weigelt, B.; Zamarin, D.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Compositional and architectural characterization of high-grade serous ovarian carcinomas using single cell technologies and multiplex microscopy
    Meeting Abstract

    Kim, S. H.; Holland, A.; Jimenez-Sanchez, A.; Bykov, Y.; Fromme, R. M.; Stylianou, A.; Walther, T.; Liu, C.; Leitao, M. M. Jr; Zivanovic, O.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer
    Meeting Abstract

    Friedman, C. F.; Snyder, A.; Abu-Rustum, N. R.; Broach, V.; Brown, C. L.; Bykov, Y.; Cadoo, K. A.; Chi, D. S.; Cohen, S.; Eid, K. T.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Phase I/II study to evaluate systemic durvalumab plus intraperitoneal (IP) ONCOS-102 in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Interim phase I clinical and translational results
    Meeting Abstract

    Zamarin, D.; Odunsi, K.; Slomovitz, B. M.; Duska, L. R.; Nemunaitis, J. J.; Reilley, M.; Bykov, Y.; Holland, A.; Hubbard-Lucey, V. M.; Shohara, L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save